Explore

Trendline Trendline
Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate

Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate

Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate
Trendline Trendline
Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Enhance Innovation

Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Enhance Innovation

Nona Biosciences Appoints Dr. Josh Xiao as Chief Scientific Officer to Enhance Innovation
Trendline Trendline
Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth

Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth

Nona Biosciences Unveils New Brand Identity to Support Biotherapeutic Growth
Trendline Trendline
Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy

Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy

Thermo Fisher Scientific Launches New Bioreactor for Cell Therapy
Trendline Trendline
Research Highlights Manufacturability Challenges of Bispecific Antibodies

Research Highlights Manufacturability Challenges of Bispecific Antibodies

Research Highlights Manufacturability Challenges of Bispecific Antibodies
Trendline Trendline
FUJIFILM Biosciences and NextCell Launch Platform for Stromal Cell Research

FUJIFILM Biosciences and NextCell Launch Platform for Stromal Cell Research

FUJIFILM Biosciences and NextCell Launch Platform for Stromal Cell Research
Trendline Trendline
GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations

GC Therapeutics Appoints Stefan Irion as Chief Scientific Officer to Advance Cell Therapy Innovations
Trendline Trendline
Bayer Acquires Perfuse Therapeutics to Enhance Ophthalmology Offerings

Bayer Acquires Perfuse Therapeutics to Enhance Ophthalmology Offerings

Bayer Acquires Perfuse Therapeutics to Enhance Ophthalmology Offerings
Trendline Trendline
Novelty Nobility Expands AGC Biologics Partnership for Antibody Manufacturing

Novelty Nobility Expands AGC Biologics Partnership for Antibody Manufacturing

Novelty Nobility Expands AGC Biologics Partnership for Antibody Manufacturing
Trendline Trendline
Eascra Biotech Expands Expertise with Dr. Anne Yau to Advance RNA Therapeutics

Eascra Biotech Expands Expertise with Dr. Anne Yau to Advance RNA Therapeutics

Eascra Biotech Expands Expertise with Dr. Anne Yau to Advance RNA Therapeutics
Trendline Trendline
Novelty Nobility Expands AGC Biologics Deal for GMP Manufacturing of Antibody Drug

Novelty Nobility Expands AGC Biologics Deal for GMP Manufacturing of Antibody Drug

Novelty Nobility Expands AGC Biologics Deal for GMP Manufacturing of Antibody Drug
Trendline Trendline
Nona Biosciences Launches Updated Brand Identity to Enhance Biotherapeutic Innovation

Nona Biosciences Launches Updated Brand Identity to Enhance Biotherapeutic Innovation

Nona Biosciences Launches Updated Brand Identity to Enhance Biotherapeutic Innovation